Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ahmed Sallam

Concepts (386)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitrectomy
31
2024
59
9.830
Why?
Visual Acuity
40
2025
141
9.530
Why?
Macular Edema
18
2024
28
8.560
Why?
Phacoemulsification
18
2025
35
8.250
Why?
Cataract
14
2024
43
7.480
Why?
Cataract Extraction
15
2024
31
6.430
Why?
Intraoperative Complications
17
2025
113
6.430
Why?
Retinal Detachment
15
2024
25
5.760
Why?
Tomography, Optical Coherence
20
2024
104
5.080
Why?
Diabetic Retinopathy
10
2024
39
4.800
Why?
Uveitis
12
2024
20
4.070
Why?
Postoperative Complications
18
2024
1018
4.000
Why?
Ophthalmology
8
2023
32
3.850
Why?
Glaucoma
8
2024
32
3.620
Why?
Glucocorticoids
16
2024
229
3.420
Why?
Endophthalmitis
11
2023
24
3.340
Why?
Epiretinal Membrane
5
2024
10
3.320
Why?
Retrospective Studies
55
2025
6123
3.060
Why?
Eye Infections, Bacterial
8
2024
29
2.890
Why?
Dexamethasone
9
2023
424
2.740
Why?
Lens Implantation, Intraocular
10
2025
24
2.620
Why?
Humans
130
2025
49898
2.560
Why?
Drug Implants
9
2023
35
2.510
Why?
Triticum
4
2023
7
2.480
Why?
Comprehension
6
2024
113
2.460
Why?
Fluorescein Angiography
7
2024
33
2.270
Why?
Syphilis
5
2024
27
2.260
Why?
Hordeum
3
2022
5
2.130
Why?
Vitreoretinal Surgery
5
2024
8
2.120
Why?
Intraocular Pressure
10
2024
54
2.040
Why?
Diabetes Mellitus
4
2022
279
2.020
Why?
Eye Infections, Fungal
6
2021
19
1.940
Why?
Retinal Vessels
3
2024
14
1.930
Why?
Retinal Vein Occlusion
6
2023
14
1.920
Why?
Papilledema
4
2022
27
1.890
Why?
Retinitis Pigmentosa
2
2024
8
1.810
Why?
Aged
43
2025
9447
1.780
Why?
Middle Aged
46
2025
12285
1.730
Why?
Aged, 80 and over
26
2025
3136
1.650
Why?
Pseudophakia
6
2024
12
1.620
Why?
Male
63
2025
25437
1.610
Why?
Fluorocarbons
3
2023
49
1.500
Why?
Angiogenesis Inhibitors
7
2022
182
1.480
Why?
Fibrin
2
2023
10
1.450
Why?
Female
60
2025
26560
1.440
Why?
Retinal Diseases
7
2021
50
1.440
Why?
Intravitreal Injections
15
2023
33
1.430
Why?
Paracentesis
2
2023
13
1.430
Why?
Databases, Factual
10
2024
660
1.390
Why?
Sclera
2
2024
5
1.380
Why?
Tissue Plasminogen Activator
2
2023
110
1.340
Why?
Macular Degeneration
4
2024
27
1.300
Why?
Lenses, Intraocular
2
2022
7
1.280
Why?
Retinal Perforations
4
2023
7
1.210
Why?
Choroid
5
2024
14
1.190
Why?
Retina
7
2024
62
1.170
Why?
Fractals
2
2024
8
1.170
Why?
Internet
3
2024
261
1.140
Why?
Iris Diseases
3
2020
4
1.140
Why?
Wet Macular Degeneration
3
2022
6
1.130
Why?
Lens, Crystalline
2
2024
20
1.130
Why?
Adult
31
2024
13346
1.130
Why?
Candidiasis
3
2021
114
1.090
Why?
Follow-Up Studies
13
2024
2175
1.080
Why?
Eye Injuries
4
2024
25
1.060
Why?
Societies, Medical
3
2019
177
1.050
Why?
Pilocarpine
1
2024
25
0.960
Why?
Retinitis
2
2022
5
0.960
Why?
Lens Subluxation
1
2024
2
0.950
Why?
Endotamponade
4
2018
8
0.940
Why?
Lighting
1
2024
5
0.920
Why?
Ciliary Body
1
2024
3
0.920
Why?
Anterior Chamber
1
2023
6
0.910
Why?
Laser Coagulation
1
2024
26
0.900
Why?
Ocular Hypertension
2
2016
6
0.890
Why?
Triamcinolone Acetonide
5
2011
15
0.890
Why?
Panuveitis
2
2021
6
0.890
Why?
Anesthesia, General
3
2024
90
0.890
Why?
Germination
1
2023
5
0.860
Why?
Endoscopy
1
2024
118
0.850
Why?
Treatment Outcome
16
2024
5176
0.840
Why?
Occlusive Dressings
1
2022
6
0.840
Why?
State Medicine
5
2023
14
0.820
Why?
Artificial Intelligence
1
2023
82
0.820
Why?
HIV Seropositivity
1
2022
27
0.810
Why?
Rift Valley Fever
1
2022
1
0.810
Why?
Reproducibility of Results
8
2024
1182
0.810
Why?
Antihypertensive Agents
2
2016
124
0.810
Why?
Optic Neuropathy, Ischemic
1
2022
8
0.800
Why?
Eye Foreign Bodies
1
2022
6
0.790
Why?
Enbucrilate
1
2021
6
0.790
Why?
Tissue Adhesives
1
2021
13
0.790
Why?
Incidence
12
2024
986
0.780
Why?
Stress, Physiological
2
2019
173
0.760
Why?
Child
17
2024
6844
0.750
Why?
Varicose Veins
2
2019
19
0.750
Why?
Droughts
4
2023
9
0.750
Why?
Candida
4
2020
60
0.730
Why?
Choroiditis
1
2020
9
0.730
Why?
Retinal Vein
2
2019
3
0.690
Why?
Eye Diseases
3
2024
32
0.680
Why?
Photography
4
2013
32
0.680
Why?
Eyeglasses
1
2019
9
0.680
Why?
Crohn Disease
1
2020
90
0.670
Why?
Surgical Instruments
1
2019
27
0.670
Why?
Trichoderma
1
2019
1
0.670
Why?
Plant Diseases
1
2019
8
0.670
Why?
Suture Techniques
2
2022
57
0.650
Why?
Laser Therapy
1
2019
84
0.630
Why?
Fovea Centralis
1
2018
5
0.630
Why?
Risk Factors
11
2025
3604
0.630
Why?
Basement Membrane
1
2018
18
0.630
Why?
Imaging, Three-Dimensional
1
2019
152
0.620
Why?
HIV Infections
1
2022
355
0.620
Why?
Vascular Endothelial Growth Factor A
5
2022
183
0.610
Why?
National Health Programs
2
2015
18
0.610
Why?
Fluocinolone Acetonide
1
2017
5
0.590
Why?
Egypt
4
2022
13
0.590
Why?
Vision Disorders
5
2024
59
0.590
Why?
Air
2
2016
23
0.570
Why?
Prospective Studies
8
2024
2345
0.560
Why?
Minerals
1
2016
30
0.540
Why?
Sodium Chloride
1
2016
56
0.530
Why?
Chorioretinitis
3
2024
9
0.530
Why?
Vitreous Detachment
1
2016
1
0.530
Why?
Acetates
1
2016
49
0.530
Why?
Ophthalmic Solutions
2
2024
19
0.530
Why?
Dissection
1
2016
14
0.520
Why?
Ophthalmologic Surgical Procedures
1
2016
22
0.510
Why?
Cross-Sectional Studies
7
2024
1573
0.510
Why?
Registries
2
2018
522
0.510
Why?
Anesthesia, Local
1
2015
15
0.500
Why?
Adrenergic alpha-1 Receptor Antagonists
2
2020
8
0.490
Why?
Child, Preschool
10
2024
3875
0.490
Why?
Patient Education as Topic
4
2024
315
0.460
Why?
Microvessels
2
2024
29
0.460
Why?
Device Removal
1
2014
84
0.440
Why?
Treponema pallidum
3
2024
10
0.430
Why?
Iris
3
2022
6
0.420
Why?
Vitreous Body
5
2020
19
0.400
Why?
Scleral Buckling
3
2023
5
0.390
Why?
Optic Disk
2
2021
20
0.390
Why?
Physical Examination
2
2013
93
0.390
Why?
Mydriatics
1
2011
12
0.380
Why?
Microscopy
1
2011
58
0.370
Why?
Seasons
2
2022
81
0.360
Why?
Diagnostic Techniques, Ophthalmological
2
2023
11
0.340
Why?
Anti-Bacterial Agents
5
2024
742
0.340
Why?
Genotype
2
2023
538
0.340
Why?
United States
8
2024
4878
0.340
Why?
Fibrinolytic Agents
2
2023
125
0.330
Why?
Intraoperative Period
2
2019
45
0.330
Why?
Vision, Low
2
2022
9
0.330
Why?
Fundus Oculi
3
2024
25
0.330
Why?
Lens Capsule, Crystalline
2
2016
2
0.320
Why?
Tonometry, Ocular
2
2024
5
0.310
Why?
Adrenergic alpha-Antagonists
1
2008
27
0.310
Why?
Silicone Oils
3
2023
3
0.300
Why?
Eye Infections, Viral
1
2008
2
0.300
Why?
Ocular Hypotension
1
2008
2
0.300
Why?
Eye Infections, Parasitic
1
2008
2
0.300
Why?
Choroid Neoplasms
1
2007
6
0.300
Why?
Suction
1
2008
23
0.300
Why?
Phenotype
2
2022
728
0.290
Why?
Physicians, Family
1
2008
64
0.290
Why?
Eye Burns
1
2007
1
0.290
Why?
Search Engine
2
2024
10
0.280
Why?
Consumer Health Information
2
2024
18
0.280
Why?
Sulfonamides
1
2008
125
0.280
Why?
Hyaluronic Acid
1
2007
35
0.280
Why?
Anti-Infective Agents
1
2008
95
0.280
Why?
Adolescent
9
2024
6414
0.280
Why?
Vaccination
3
2024
275
0.260
Why?
Young Adult
8
2024
4029
0.250
Why?
Muscarinic Agonists
1
2024
11
0.240
Why?
Administration, Topical
1
2024
56
0.240
Why?
Trabeculectomy
1
2024
9
0.240
Why?
Glaucoma Drainage Implants
1
2024
6
0.240
Why?
Cohort Studies
2
2022
1403
0.240
Why?
Limbus Corneae
1
2024
8
0.240
Why?
Vitreoretinopathy, Proliferative
1
2024
3
0.230
Why?
Syphilis Serodiagnosis
1
2024
4
0.230
Why?
Melanoma
1
2007
281
0.230
Why?
Garlic
1
2024
5
0.230
Why?
Proanthocyanidins
1
2024
3
0.230
Why?
Abducens Nerve Diseases
1
2024
7
0.230
Why?
Ciliary Arteries
1
2024
3
0.230
Why?
Burns, Chemical
1
2024
9
0.230
Why?
Propensity Score
1
2024
125
0.230
Why?
Health Knowledge, Attitudes, Practice
1
2008
488
0.230
Why?
Pseudotumor Cerebri
1
2024
26
0.230
Why?
Glaucoma, Open-Angle
1
2024
21
0.220
Why?
Inflammation
3
2022
603
0.220
Why?
Tattooing
1
2023
5
0.220
Why?
Geographic Atrophy
1
2023
2
0.220
Why?
Sex Workers
1
2023
2
0.220
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2024
122
0.220
Why?
Drainage
1
2023
79
0.220
Why?
Cultural Diversity
1
2023
38
0.220
Why?
Fibrinolysin
1
2023
2
0.220
Why?
Dementia
1
2024
113
0.220
Why?
Self Report
1
2024
202
0.220
Why?
Odds Ratio
1
2025
548
0.220
Why?
Schools, Medical
1
2023
70
0.210
Why?
Retreatment
2
2014
56
0.210
Why?
ROC Curve
1
2023
225
0.210
Why?
Patient Selection
1
2024
254
0.210
Why?
Faculty, Medical
1
2023
92
0.210
Why?
Vision Screening
1
2022
11
0.210
Why?
Blood-Retinal Barrier
1
2022
5
0.210
Why?
Subretinal Fluid
1
2022
2
0.210
Why?
Disease Management
2
2021
175
0.200
Why?
Sudan
1
2022
2
0.200
Why?
Privacy
1
2022
16
0.200
Why?
Health Literacy
4
2024
130
0.200
Why?
Antibodies, Monoclonal, Humanized
2
2015
223
0.200
Why?
Cyanoacrylates
1
2021
6
0.200
Why?
Fibrin Tissue Adhesive
1
2021
12
0.200
Why?
Recombinant Fusion Proteins
1
2022
186
0.200
Why?
Prednisone
1
2022
100
0.200
Why?
Eye Abnormalities
1
2021
24
0.200
Why?
Vision, Ocular
1
2021
9
0.200
Why?
Infant
5
2024
3572
0.190
Why?
Eye
1
2021
24
0.190
Why?
Ecosystem
1
2022
64
0.190
Why?
Prevalence
3
2022
956
0.190
Why?
Genome-Wide Association Study
1
2022
163
0.190
Why?
Sensitivity and Specificity
1
2023
858
0.190
Why?
Tomography, X-Ray Computed
2
2022
1150
0.190
Why?
Diabetes Mellitus, Type 1
1
2024
201
0.190
Why?
Disease Outbreaks
1
2022
123
0.190
Why?
Prolapse
1
2020
6
0.190
Why?
Randomized Controlled Trials as Topic
1
2024
550
0.180
Why?
Fungemia
1
2021
37
0.180
Why?
Electronic Health Records
3
2018
209
0.180
Why?
Swine
1
2021
396
0.180
Why?
Oximetry
2
2011
65
0.180
Why?
Ophthalmoscopy
1
2020
14
0.180
Why?
Macula Lutea
1
2020
3
0.180
Why?
Carcinoma, Hepatocellular
1
2022
194
0.170
Why?
Bacteria
1
2022
219
0.170
Why?
Retinal Pigment Epithelium
1
2020
11
0.170
Why?
Blindness
2
2022
31
0.170
Why?
Algorithms
1
2023
613
0.170
Why?
Substance Abuse, Intravenous
1
2020
43
0.170
Why?
Polymorphism, Single Nucleotide
1
2022
482
0.170
Why?
Fusariosis
1
2019
6
0.170
Why?
Plant Roots
1
2019
33
0.170
Why?
Fusarium
1
2019
31
0.160
Why?
Referral and Consultation
3
2013
284
0.160
Why?
Quantitative Trait Loci
1
2019
42
0.160
Why?
Hepatitis C
1
2020
80
0.160
Why?
Liver Neoplasms
1
2022
329
0.160
Why?
MicroRNAs
1
2022
347
0.160
Why?
Animals
3
2024
13100
0.160
Why?
Emergencies
2
2009
84
0.160
Why?
Water
1
2019
74
0.160
Why?
Antibiotic Prophylaxis
1
2019
61
0.160
Why?
Chromosome Mapping
1
2019
158
0.160
Why?
Equipment Design
1
2019
286
0.160
Why?
Gaucher Disease
1
2018
14
0.150
Why?
Alleles
1
2019
251
0.150
Why?
Recurrence
2
2011
658
0.150
Why?
Surgical Wound Infection
1
2019
114
0.150
Why?
Sulfur Hexafluoride
1
2017
2
0.150
Why?
Treatment Failure
1
2018
116
0.150
Why?
Drug Therapy, Combination
2
2016
380
0.150
Why?
Diabetes Mellitus, Type 2
1
2024
483
0.150
Why?
Eye Diseases, Hereditary
1
2017
5
0.140
Why?
Fatty Acids
1
2018
143
0.140
Why?
Inheritance Patterns
1
2017
22
0.140
Why?
Penicillins
1
2017
28
0.140
Why?
Contrast Media
1
2018
186
0.140
Why?
Time Factors
3
2020
2891
0.140
Why?
Video Recording
1
2016
79
0.130
Why?
Microsurgery
2
2024
30
0.130
Why?
Drug Combinations
1
2016
126
0.130
Why?
Anesthetics, General
1
2015
4
0.130
Why?
Visually Impaired Persons
1
2015
1
0.120
Why?
Dose-Response Relationship, Drug
2
2016
1354
0.120
Why?
England
2
2012
45
0.120
Why?
Anesthetics, Local
1
2015
74
0.120
Why?
Acute Disease
2
2021
367
0.120
Why?
Microscopy, Acoustic
1
2013
5
0.110
Why?
Language
2
2024
134
0.110
Why?
Diagnosis, Differential
3
2017
1036
0.110
Why?
Glaucoma, Neovascular
1
2012
2
0.110
Why?
Infusions, Intravenous
2
2017
212
0.110
Why?
Syndrome
2
2011
237
0.090
Why?
Risk Assessment
1
2016
1254
0.090
Why?
Mutation
1
2017
1292
0.090
Why?
Muscle Hypotonia
1
2011
21
0.090
Why?
Risperidone
1
2011
25
0.090
Why?
Eye Hemorrhage
1
2010
1
0.090
Why?
Cranial Sinuses
1
2010
10
0.090
Why?
Carotid Artery Injuries
1
2010
13
0.090
Why?
Arteriovenous Fistula
1
2010
22
0.090
Why?
Prostaglandins F, Synthetic
1
2009
1
0.080
Why?
Anti-Inflammatory Agents
1
2011
160
0.080
Why?
Prednisolone
1
2009
55
0.080
Why?
Carbonic Anhydrase Inhibitors
1
2008
5
0.080
Why?
Antipsychotic Agents
1
2011
231
0.080
Why?
Acetazolamide
1
2008
18
0.080
Why?
Oxygen
1
2011
323
0.080
Why?
Pupil
1
2008
29
0.080
Why?
Vitreous Hemorrhage
1
2008
4
0.080
Why?
Prostatic Hyperplasia
1
2008
38
0.080
Why?
Mass Screening
1
2011
346
0.080
Why?
Injections
1
2008
56
0.080
Why?
Electroretinography
2
2018
17
0.070
Why?
Models, Biological
1
2011
719
0.070
Why?
Cefuroxime
1
2007
3
0.070
Why?
Cefazolin
1
2007
10
0.070
Why?
Capsulorhexis
1
2007
1
0.070
Why?
Rupture
1
2007
24
0.070
Why?
Astigmatism
1
2007
5
0.070
Why?
Neoplasm Metastasis
1
2007
235
0.070
Why?
Chronic Disease
1
2009
565
0.070
Why?
Clinical Competence
1
2008
395
0.060
Why?
Reagins
1
2024
2
0.060
Why?
Posterior Eye Segment
1
2024
2
0.060
Why?
Sex Distribution
1
2024
135
0.060
Why?
Prosthesis Implantation
1
2024
46
0.060
Why?
Antibodies, Bacterial
1
2024
27
0.060
Why?
Rumen
1
2024
1
0.060
Why?
Tannins
1
2024
3
0.060
Why?
Fermentation
1
2024
9
0.060
Why?
Goats
1
2024
11
0.060
Why?
Diplopia
1
2024
19
0.060
Why?
Teaching Materials
1
2024
30
0.060
Why?
Animal Feed
1
2024
55
0.060
Why?
Reading
1
2024
82
0.060
Why?
Antifungal Agents
1
2006
343
0.060
Why?
Immunoglobulin G
1
2024
184
0.050
Why?
Anesthesia
1
2024
73
0.050
Why?
Surgical Flaps
1
2024
114
0.050
Why?
Homosexuality, Male
1
2023
52
0.050
Why?
Retinal Ganglion Cells
1
2022
13
0.050
Why?
Traction
1
2021
7
0.050
Why?
Reoperation
2
2014
453
0.050
Why?
Socioeconomic Factors
1
2023
583
0.040
Why?
Health Status Disparities
1
2023
196
0.040
Why?
Atrophy
1
2020
38
0.040
Why?
Diet
1
2024
553
0.040
Why?
Emergency Service, Hospital
1
2024
487
0.040
Why?
Healthcare Disparities
1
2023
279
0.040
Why?
Europe
1
2019
75
0.040
Why?
Pandemics
1
2024
566
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2022
824
0.040
Why?
Administration, Oral
2
2011
433
0.040
Why?
Glucosylceramidase
1
2018
8
0.040
Why?
Enzyme Replacement Therapy
1
2018
17
0.040
Why?
Visual Fields
1
2018
36
0.040
Why?
Transplantation, Autologous
1
2020
462
0.040
Why?
Prone Position
1
2017
31
0.040
Why?
Genes, Recessive
1
2017
16
0.040
Why?
Consanguinity
1
2017
18
0.040
Why?
Heterozygote
1
2017
81
0.040
Why?
Pedigree
1
2017
125
0.040
Why?
Recombinant Proteins
1
2018
482
0.030
Why?
DNA Mutational Analysis
1
2017
176
0.030
Why?
Genetic Association Studies
1
2017
115
0.030
Why?
Genetic Testing
1
2017
119
0.030
Why?
Rupture, Spontaneous
1
2016
19
0.030
Why?
Practice Guidelines as Topic
1
2019
458
0.030
Why?
Pregnancy
1
2023
2468
0.030
Why?
Survival Analysis
1
2016
670
0.030
Why?
Choroidal Neovascularization
1
2013
19
0.030
Why?
Gonioscopy
1
2012
3
0.030
Why?
Age Distribution
1
2013
169
0.030
Why?
Neovascularization, Pathologic
1
2012
153
0.020
Why?
Retinal Artery
1
2011
5
0.020
Why?
Coloring Agents
1
2011
67
0.020
Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
9
0.020
Why?
Indocyanine Green
1
2011
34
0.020
Why?
Dopamine Antagonists
1
2011
21
0.020
Why?
Angiography
1
2011
127
0.020
Why?
Injections, Intraocular
1
2010
2
0.020
Why?
Regional Blood Flow
1
2011
106
0.020
Why?
Methylprednisolone
1
2010
38
0.020
Why?
Orbit
1
2010
27
0.020
Why?
Chemotherapy, Adjuvant
1
2011
121
0.020
Why?
Adrenal Cortex Hormones
1
2011
99
0.020
Why?
Schizophrenia
1
2011
257
0.020
Why?
Immunosuppressive Agents
1
2011
226
0.020
Why?
Sweden
1
2007
10
0.020
Why?
Sallam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description